Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Neonatology

Free Subscription Articles published in Thorax Retrieve available abstracts of 46 articles: HTML format

Single Articles

April 2024
1. GRUDZINSKA FS, Scott A
   Unravelling the neutrophil enigma: a new insight into RSV-induced bronchiolitis in infants.
   Thorax. 2024 Apr 4:thorax-2023-221130. doi: 10.1136/thorax-2023-221130.
   PubMed    
   
   
   February 2024
2. WATKINS WJ, Course CW, Cousins M, Hart K, et al
   Impact of ambient air pollution on lung function in preterm-born school-aged children.
   Thorax. 2024 Feb 15:thorax-2023-220233. doi: 10.1136/thorax-2023-220233.
   PubMed     Abstract available
   
   
   January 2024
3. HOWELLS A, Riley M, Samuels M, Aurora P, et al
   Retrospective analysis of referrals for hypoxic challenge testing in children born preterm.
   Thorax. 2024 Jan 12:thorax-2023-220677. doi: 10.1136/thorax-2023-220677.
   PubMed     Abstract available
   
   
   December 2023
4. LV Q, Gallardo-Estrella L, Andrinopoulou ER, Chen Y, et al
   Automatic analysis of bronchus-artery dimensions to diagnose and monitor airways disease in cystic fibrosis.
   Thorax. 2023;79:13-22.
   PubMed     Abstract available
   
   
   
5. ROBINSON E, Sawhney S, Cortina-Borja M, David AL, et al
   Neutrophil responses to RSV infection show differences between infant and adult neutrophils.
   Thorax. 2023 Dec 2:thorax-2023-220081. doi: 10.1136/thorax-2023-220081.
   PubMed     Abstract available
   
   
   
6. AL-ADHAMI A, Al-Aloul M, Rushton S, Thompson RD, et al
   Early experience of a new national lung allocation scheme in the UK based on clinical urgency.
   Thorax. 2023;78:1206-1214.
   PubMed     Abstract available
   
   
   November 2023
7. AHN SY, Chang YS, Lee MH, Sung S, et al
   Five-year follow-up of phase II trial of stromal cells for bronchopulmonary dysplasia.
   Thorax. 2023;78:1105-1110.
   PubMed     Abstract available
   
   
   October 2023
8. GRANGER E, Davies G, Keogh RH
   Emulated trial investigating effects of multiple treatments: estimating combined effects of mucoactive nebulisers in cystic fibrosis using registry data.
   Thorax. 2023;78:1011-1018.
   PubMed     Abstract available
   
   
   September 2023
9. ZIVANOVIC S, Chaban B
   Increasing respiratory burden of prematurity: can we turn the tide?
   Thorax. 2023 Sep 21:thorax-2023-220606. doi: 10.1136/thorax-2023-220606.
   PubMed    
   
   
   August 2023
10. KWOK TC, Poulter C, Algarni S, Szatkowski L, et al
    Respiratory management and outcomes in high-risk preterm infants with development of a population outcome dashboard.
    Thorax. 2023 Aug 28:thorax-2023-220174. doi: 10.1136/thorax-2023-220174.
    PubMed     Abstract available
    
    
    
11. ROWBOTHAM NJ, Smith S, Elliott ZC, Cupid B, et al
    A refresh of the top 10 research priorities in cystic fibrosis.
    Thorax. 2023;78:840-843.
    PubMed     Abstract available
    
    
    
12. CASEY M, Gabillard-Lefort C, McElvaney OF, McElvaney OJ, et al
    Effect of elexacaftor/tezacaftor/ivacaftor on airway and systemic inflammation in cystic fibrosis.
    Thorax. 2023;78:835-839.
    PubMed     Abstract available
    
    
    July 2023
13. GIE A, Davies C, Vaida F, Morrison J, et al
    Lung function tracking in children with perinatally acquired HIV following early antiretroviral therapy initiation.
    Thorax. 2023 Jul 21:thorax-2023-220197. doi: 10.1136/thorax-2023-220197.
    PubMed     Abstract available
    
    
    May 2023
14. SMITH EF, Hemy NR, Hall GL, Wilson AC, et al
    Risk factors for poorer respiratory outcomes in adolescents and young adults born preterm.
    Thorax. 2023 May 19:thorax-2022-219634. doi: 10.1136/thorax-2022-219634.
    PubMed     Abstract available
    
    
    April 2023
15. PERREM L, Stanojevic S, Solomon M, Grasemann H, et al
    Evaluation of clinically relevant changes in the lung clearance index in children with cystic fibrosis and healthy controls.
    Thorax. 2023;78:362-367.
    PubMed     Abstract available
    
    
    March 2023
16. BASHFORD J, Flowers W, Haworth C, Ryan J, et al
    Evaluation of a novel ELISA test using synthetic mycolic acid antigens for serodiagnosis of non-tuberculous mycobacterial (NTM) infections.
    Thorax. 2023;78:309-312.
    PubMed     Abstract available
    
    
    
17. JONES AM
    Patient registry data highlights international differences in survival in cystic fibrosis.
    Thorax. 2023;78:223-224.
    PubMed    
    
    
    
18. CORIATI A, Ma X, Sykes J, Stanojevic S, et al
    Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand.
    Thorax. 2023;78:242-248.
    PubMed     Abstract available
    
    
    February 2023
19. LI Y, Seidl E, Knoflach K, Gothe F, et al
    ABCA3-related interstitial lung disease beyond infancy.
    Thorax. 2023 Feb 20:thorax-2022-219434. doi: 10.1136/thorax-2022-219434.
    PubMed     Abstract available
    
    
    
20. SVEDBERG M, Imberg H, Gustafsson PM, Tiddens H, et al
    Longitudinal lung clearance index and association with structural lung damage in children with cystic fibrosis.
    Thorax. 2023;78:176-182.
    PubMed    
    
    
    
21. COUSINS M, Hart K, Kotecha SJ, Henderson AJ, et al
    Characterising airway obstructive, dysanaptic and PRISm phenotypes of prematurity-associated lung disease.
    Thorax. 2023 Feb 1:thoraxjnl-2022-219301. doi: 10.1136/thorax-2022-219301.
    PubMed     Abstract available
    
    
    January 2023
22. SAYNOR ZL, Cunningham S, Morrison L, Main E, et al
    Exercise as airway clearance therapy (ExACT) in cystic fibrosis: a UK-based e-Delphi survey of patients, caregivers and health professionals.
    Thorax. 2023;78:88-91.
    PubMed     Abstract available
    
    
    
23. KING JA, Desai A, Semple T, Nicholson AG, et al
    Case-based discussion: neonates on extracorporeal membrane oxygenation for undiagnosed recalcitrant pulmonary hypertension-management challenges.
    Thorax. 2023;78:107-109.
    PubMed     Abstract available
    
    
    
24. COX NS, Eldridge B, Rawlings S, Dreger J, et al
    Web-based physical activity promotion in young people with CF: a randomised controlled trial.
    Thorax. 2023;78:16-23.
    PubMed     Abstract available
    
    
    
25. RADTKE T
    Role of physical activity and airway clearance therapy in cystic fibrosis: moving forward in a rapidly changing landscape.
    Thorax. 2023;78:3-4.
    PubMed    
    
    
    December 2022
26. GIE A, Toelen J
    Chronic neonatal lung disease: time to look beyond the alveolus.
    Thorax. 2022;77:1161-1162.
    PubMed    
    
    
    September 2022
27. KEOGH RH, Cosgriff R, Andrinopoulou ER, Brownlee KG, et al
    Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials.
    Thorax. 2022;77:873-881.
    PubMed     Abstract available
    
    
    July 2022
28. CRUMP C, Sundquist J, Sundquist K
    Preterm or early term birth and long-term risk of asthma into midadulthood: a national cohort and cosibling study.
    Thorax. 2022 Jul 30. pii: thorax-2022-218931. doi: 10.1136/thorax-2022-218931.
    PubMed     Abstract available
    
    
    
29. FUJIOGI M, Zhu Z, Raita Y, Ooka T, et al
    Nasopharyngeal lipidomic endotypes of infants with bronchiolitis and risk of childhood asthma: a multicentre prospective study.
    Thorax. 2022 Jul 30. pii: thorax-2022-219016. doi: 10.1136/thorax-2022-219016.
    PubMed     Abstract available
    
    
    June 2022
30. THORNTON C, Somayaji R, Chu A, Parkins MD, et al
    Human papillomavirus (HPV) and cervical dysplasia in adult female cystic fibrosis (CF) lung transplant recipients.
    Thorax. 2022;77:625-627.
    PubMed     Abstract available
    
    
    
31. NICHOLS DP, Singh PK, Baines A, Caverly LJ, et al
    Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial.
    Thorax. 2022;77:581-588.
    PubMed     Abstract available
    
    
    May 2022
32. HEYDARIAN M, Oak P, Zhang X, Kamgari N, et al
    Relationship between impaired BMP signalling and clinical risk factors at early-stage vascular injury in the preterm infant.
    Thorax. 2022 May 17. pii: thoraxjnl-2021-218083.
    PubMed     Abstract available
    
    
    
33. SCHULTZ A
    Adherence to CF treatment can be improved with the right approach!
    Thorax. 2022;77:428.
    PubMed    
    
    
    
34. WILDMAN MJ, O'Cathain A, Maguire C, Arden MA, et al
    Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial.
    Thorax. 2022;77:461-469.
    PubMed     Abstract available
    
    
    April 2022
35. DOYLE LW, Ranganathan S, Cheong J
    Bronchopulmonary dysplasia and expiratory airflow at 8 years in children born extremely preterm in the post-surfactant era.
    Thorax. 2022 Apr 22. pii: thoraxjnl-2022-218792.
    PubMed     Abstract available
    
    
    
36. BARDSEN T, Roksund OD, Benestad MR, Hufthammer KO, et al
    Tracking of lung function from 10 to 35 years after being born extremely preterm or with extremely low birth weight.
    Thorax. 2022 Apr 11. pii: thoraxjnl-2021-218400.
    PubMed     Abstract available
    
    
    
37. LENNEY W, Marlow N
    Extreme prematurity and adult respiratory disease.
    Thorax. 2022 Apr 11. pii: thoraxjnl-2021-218599.
    PubMed    
    
    
    
38. HORSLEY AR, Belcher J, Bayfield K, Bianco B, et al
    Longitudinal assessment of lung clearance index to monitor disease progression in children and adults with cystic fibrosis.
    Thorax. 2022;77:357-363.
    PubMed     Abstract available
    
    
    March 2022
39. 
    Correction: Association of asthma severity and educational attainment at age 6-7 years in a birth cohort: population-based record-linkage study.
    Thorax. 2022;77:e2.
    PubMed    
    
    
    
40. HERBERT S, Rowbotham NJ, Smith S, Wilson P, et al
    Exploring the challenges of accessing medication for patients with cystic fibrosis.
    Thorax. 2022;77:295-297.
    PubMed     Abstract available
    
    
    February 2022
41. PERREM LM, McNally P, Ratjen F
    Apples to apples? Comparative analyses of national CF registries.
    Thorax. 2022;77:112-113.
    PubMed    
    
    
    
42. SCHLUTER DK, Ostrenga JS, Carr SB, Fink AK, et al
    Lung function in children with cystic fibrosis in the USA and UK: a comparative longitudinal analysis of national registry data.
    Thorax. 2022;77:136-142.
    PubMed     Abstract available
    
    
    December 2021
43. BAYFIELD KJ, Douglas TA, Rosenow T, Davies JC, et al
    Time to get serious about the detection and monitoring of early lung disease in cystic fibrosis.
    Thorax. 2021;76:1255-1265.
    PubMed     Abstract available
    
    
    November 2021
44. CUYX S, Ramalho AS, Corthout N, Fieuws S, et al
    Rectal organoid morphology analysis (ROMA) as a promising diagnostic tool in cystic fibrosis.
    Thorax. 2021;76:1146-1149.
    PubMed     Abstract available
    
    
    October 2021
45. TRAPPE A, Donnelly SC, McNally P, Coppinger JA, et al
    Role of extracellular vesicles in chronic lung disease.
    Thorax. 2021;76:1047-1056.
    PubMed     Abstract available
    
    
    August 2021
46. YOUNG K, Sosenko I, Claure N
    Placental dysfunction and impaired fetal growth: a relationship with bronchopulmonary dysplasia and pulmonary hypertension.
    Thorax. 2021 Aug 24. pii: thoraxjnl-2021-217476.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neonatology is free of charge.